Creo Medical (GB:CREO) has released an update.
Canaccord Genuity Group Inc. has reported a major change in their holdings of Creo Medical Group PLC, crossing a threshold on 27 August 2024. The financial institution now holds 9.9548% of voting rights, a change from their previous notification. The notification, completed in Blackpool, England, indicates Canaccord Genuity’s increased stake in the medical company.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
